关注
Evans DG*, Evans G*
Evans DG*, Evans G*
University of Manchester
在 mft.nhs.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
L Jostins, S Ripke, RK Weersma, RH Duerr, DP McGovern, KY Hui, ...
Nature 491 (7422), 119-124, 2012
51752012
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies
A Antoniou, PDP Pharoah, S Narod, HA Risch, JE Eyfjord, JL Hopper, ...
American journal of human genetics 72 (5), 1117, 2003
47592003
Genome-wide association study identifies novel breast cancer susceptibility loci
DF Easton, KA Pooley, AM Dunning, PDP Pharoah, D Thompson, ...
Nature 447 (7148), 1087-1093, 2007
28132007
Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
KB Kuchenbaecker, JL Hopper, DR Barnes, KA Phillips, TM Mooij, ...
Jama 317 (23), 2402-2416, 2017
27792017
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Lancet (London, England) 397 (10285), 1637, 2021
2181*2021
Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations
TR Rebbeck, HT Lynch, SL Neuhausen, SA Narod, L Van't Veer, ...
New England Journal of Medicine 346 (21), 1616-1622, 2002
18752002
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality
SM Domchek, TM Friebel, CF Singer, DG Evans, HT Lynch, C Isaacs, ...
Jama 304 (9), 967-975, 2010
16942010
Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group
TR Rebbeck, T Friebel, HT Lynch, SL Neuhausen, L Van’t Veer, ...
Journal of clinical oncology 22 (6), 1055-1062, 2004
15282004
Low-penetrance susceptibility to breast cancer due to CHEK2* 1100delC in noncarriers of BRCA1 or BRCA2 mutations
H Meijers-Heijboer, A van den Ouweland, J Klijn, M Wasielewski, ...
Nature genetics 31 (1), 55-59, 2002
14122002
Malignant peripheral nerve sheath tumours in neurofibromatosis 1
DGR Evans, ME Baser, J McGaughran, S Sharif, E Howard, A Moran
Journal of medical genetics 39 (5), 311-314, 2002
14032002
Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)
SR Cairns, JH Scholefield, RJ Steele, MG Dunlop, HJW Thomas, ...
Gut 59 (5), 666-689, 2010
13382010
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).
MO Leach, CR Boggis, AK Dixon, DF Easton, RA Eeles, DG Evans, ...
Lancet 365 (9473), 1769, 2005
13112005
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
K Michailidou, P Hall, A Gonzalez-Neira, M Ghoussaini, J Dennis, ...
Nature genetics 45 (4), 353-361, 2013
12712013
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1
RE Ferner, SM Huson, N Thomas, C Moss, H Willshaw, DG Evans, ...
Journal of medical genetics 44 (2), 81-88, 2007
11912007
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
N Rahman, S Seal, D Thompson, P Kelly, A Renwick, A Elliott, S Reid, ...
Nature genetics 39 (2), 165-167, 2007
11842007
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
J Burn, AM Gerdes, F Macrae, JP Mecklin, G Moeslein, S Olschwang, ...
The Lancet 378 (9809), 2081-2087, 2011
11402011
The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in …
SR Lakhani, MJ Van De Vijver, J Jacquemier, TJ Anderson, PP Osin, ...
Journal of clinical oncology 20 (9), 2310-2318, 2002
11252002
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
N Mavaddat, S Peock, D Frost, S Ellis, R Platte, E Fineberg, DG Evans, ...
JNCI: Journal of the National Cancer Institute 105 (11), 812-822, 2013
10892013
Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas
C Palles, JB Cazier, KM Howarth, E Domingo, AM Jones, P Broderick, ...
Nature Genetics, 2012
10842012
The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women
MN Harvie, M Pegington, MP Mattson, J Frystyk, B Dillon, G Evans, ...
International journal of obesity 35 (5), 714-727, 2011
10442011
系统目前无法执行此操作,请稍后再试。
文章 1–20